No Data
No Data
JonesTrading Maintains Editas Medicine(EDIT.US) With Hold Rating
Cautious Hold Rating on Editas Medicine Amid Early Development Stage and Long-Term Milestones
BofA Securities Maintains Editas Medicine(EDIT.US) With Sell Rating, Maintains Target Price $1
A Quick Look at Today's Ratings for Editas Medicine(EDIT.US), With a Forecast Between $1 to $5
Sell Rating for Editas Medicine Amid Strategic Shift and Competitive Pressures
Buy Rating for Editas Medicine Driven by Promising Preclinical Advances and Strong Financial Position